avatar Cleveland Clinic Home Care Services Services

Pages

  • Page 1

    I M N G O R F Transforming Medicine 2005 ANNUAL REPORT A N S R T


  • Page 2

    I G N M R O F Transforming Medicine A S N R T


  • Page 3

    Cleveland Clinic is transforming medicine. It is improving 1 patient care, focusing research on new therapies and cures, and training new physicians in patient-based science. In 2005, Cleveland Clinic challenged old ways by pioneer- ing new surgical techniques, applying new treatments and launching powerful innovations. It transformed the way we see the body and understand disease. It altered the way patients view their health. And even while it transforms medi- cine, Cleveland Clinic is transforming itself. New programs. New facilities. And new collaborations that put patients first.


  • Page 4

    Dear Friends: In 2005, Cleveland Clinic continued to move As Nelson Mandela noted, “Education is the forward. We attained remarkable clinical results, most powerful weapon which you can use to advanced patient-based research, and strength- change the world.” Cleveland Clinic is trans- ened our commitment to the health and educa- forming medical education through the Lerner tion of the communities we serve. College of Medicine of Case Western Reserve University. We had approximately 1,000 ap- We experienced a busy year in patient care. plicants for 33 places in the 2006 entering Outpatient visits rose by four percent over 2004, class. Not only is that 400 more applicants and total visits to our family health and ambula- than in 2004, but their Medical College tory surgery centers went up 5 percent. Visits to Admission Test scores averaged four points our Emergency Department climbed 6 percent. above the national average – approaching the Hospital admissions were down slightly, but this same level as applicants to the nation’s top was a result of our having moved obstetrics to medical schools. Having reached this level Hillcrest Hospital and the inpatient psychiatry in only three short years is astounding. unit to Lutheran Hospital. As an institution at the leading edge of medical The Cleveland Clinic 2005 case mix index (a mea- innovation, Cleveland Clinic is among the first sure of the complexity of patient illnesses reported to confront a variety of conflict of interest issues. by Medicare) was the highest of any of the U.S. An independent review of our conflict of interest News & World Report’s four top-ranked hospitals. policies undertaken in 2005 has validated those In 2005, we celebrated the 60th anniversary policies and strengthened our resolve to set the of the Division of Research, now the Lerner standard for excellence in this area. As part of Research Institute. A critical part of our mission, this commitment, we have invited colleagues the Lerner Research Institute has rededicated and peer institutions from around the world to a itself to patient-based research and the quest special conflict of interest summit at Cleveland for new treatments and cures. This year, outside Clinic in September 2006. funding for research at Cleveland Clinic jumped 21 percent, with a 14 percent increase from the National Institutes of Health alone.


  • Page 5

    Cleveland Clinic continued the expansion and our neighborhoods. Finally, we must never forget enhancement of our physical plant in 2005. the most important figure at the entire Cleveland The foundation of the new Arnold and Sydell Clinic – the patient. As long as we keep ourselves Miller Family Pavilion was completed, and the focused on the patient, I am confident that we 2 3 site was prepared for the Glickman Tower along- can be the leading academic medical center in side. Plans have been announced for an addition America. to our parking garage on East 93rd Street and Euclid Avenue. We also continue to enhance and upgrade the facilities at our family health and ambulatory surgery centers. One of the achievements of which I am proudest in 2005 is the growth in our patient satisfaction scores over the past several years. Thanks to the efforts of our World Class Service initiative, patient satisfaction at Cleveland Clinic is well above the national average. At the same time, our employee satisfaction is the highest ever. Both of these accomplishments came at a time when Sincerely, our average occupancy rate was at 90 percent. We will continue to improve these scores until we exceed the expectations of every patient in all areas of service and care. While we are proud of our success, we must Delos M. Cosgrove, M.D. guard against overconfidence. We need to main- CEO and President tain our focus on continually improving quality and outcomes. We will continue to build our community outreach initiatives and do even more to enhance health awareness and education in


  • Page 6

    The Year in Review


  • Page 7

    Overall Ranking Cleveland Clinic 4th Alone in its Field # Heart and Vascular Institute 1 for 11 years in a row In America’s Top Two Glickman Urological Institute 6 years in a row Digestive Disease Center 5 years 4 5 In America’s Top Ten Rheumatology 4th Orthopaedics 5th Kidney Disease 6th Neurology and Neurosurgery 6th Ear, Nose and Throat 7th Hormonal Disorders 8th Gynecology 9th Respiratory Disorders 10th Highly Ranked Geriatrics 12th Cancer 14th Ophthalmology 15th Rehabilitation 20th Psychiatry 23th


  • Page 8

    N S F A O R R T M I N G


  • Page 9

    Women’s hearts are different. They express disease differently. They respond differently to treat- ment. And they don’t get enough attention. So Cleveland Clinic, America’s No. 1 heart program, is transforming women’s heart care with the opening of its new Women’s 6 7 Cardiovascular Center. Under the direction of Leslie Cho, M.D., the Women’s Cardiovascular Center has 10 women cardiologists and access to the full range of Cleveland Clinic cardiac services. “There is less awareness of heart disease and its symptoms among women,” says Dr. Cho. “Some physicians may not treat it aggressively enough. Until recently, treatment and research have focused on men. I’m pleased with this opportunity to develop a center where we can treat, educate and scientifically explore women and their hearts.” Leslie Cho, M.D., Director, Women’s Cardiovascular Center, with intravascular ultrasound images of atherosclerosis in coronary arteries.


  • Page 10

    Both C-reactive protein and cholesterol must The spread of viruses and prostate cancer be lowered to control coronary artery disease could be halted by activation of a newly A Cleveland Clinic-led study shows that intensive discovered cellular mechanism use of cholesterol-lowering statins reduces the A team led by Robert H. Silverman, Ph.D., Cancer progression of plaque buildup in coronary arteries Biology, discovers that activating RNase L, a type by reducing C-reactive protein (CRP), a measure of of protein found in cells, also activates the body’s arterial inflammation. This is the first evidence that own anti-viral and cancer-fighting mechanisms. targeting CRP could reduce the disease burden, This discovery will help researchers focus drug- says study leader Steven E. Nissen, M.D., Cardio- development efforts on activating these natural vascular Medicine. Results suggest that statin defenses. therapy should target CRP as well as cholesterol. More comprehensive genetic testing is needed The body’s biological clock among patients with polyp conditions affects cancer treatment New research into genetic mutations among A molecular mechanism is discovered that links patients with common polyp conditions concludes the body’s internal clock to daily variations in how that a more comprehensive genetic analysis is a patient responds to cancer treatment. The study, needed to determine each person’s risk for devel- led by Marina P. Antoch, Ph.D., Cancer Biology, oping colon and other cancers. The study, led could contribute to more effective timing of cancer by Charis Eng, M.D., Ph.D., Genomic Medicine treatments. Institute, suggests that better genetic information also could tell physicians whether to test other There’s a better test for spotting genetic members of a patient’s family to assess their risk abnormalities in cancer patients of cancer even before polyps form. A new form of genetic testing, called conversion analysis, can pinpoint genetic abnormalities in Weakly linked protein clusters are as important some patients with inherited colon cancer. Graham to influencing cell shape and mobility as strongly Casey, Ph.D., Cancer Biology, led the study, which linked clusters shows that conversion analysis overcomes the The common biomedical wisdom is reversed limitations of gene sequencing, the previous gold when research led by Jun Qin, Ph.D., Molecular standard, and can identify genetic abnormalities in Cardiology, reveals that both strong and weak links a larger percentage of patients. among protein clusters affect cell development. Previously, strong links received most of the atten- There is a new medication tion by researchers attempting to understand how to treat adults with kidney disease cells behave in cellular and disease processes. The Ronald M. Bukowski, M.D., Hematology and finding opens the door to new areas of exploration Oncology, led a 900-patient international study of and possible therapies. the drug Nexavar (sorafenib tosylate). The study shows patients taking the oral medication are able A single gene is responsible for two to stave off the disease for twice as long as those separate neurological disorders occurring who did not take it. The research contributes to in patients at the same time FDA approval of the drug. Epilepsy and paroxysmal dyskinesia are distinct neurological disorders with similar manifestations. Migraine headaches may be surgically treatable In some families, there are individuals who can Jennifer S. Kriegler, M.D., Neurology, co-authors a have either or both, with age-related expression. study investigating the efficacy of surgical deactiva- The fact that individuals can have one or both tion of migraine headache trigger sites. Ninety-two conditions suggests that the two disorders share a percent of patients in the treatment group demon- common genetic origin. Now, a team led by Qing strate at least a 50 percent improvement, with 31 Wang, Ph.D., Molecular Cardiology, is the first to percent experiencing elimination of their migraines. discover a gene linked to the simultaneous occur- Additional studies are necessary to clarify the mecha- rence of these two neurological disorders. The nism of action and to determine long-term results. discovery provides insight into the development of these diseases and begins to develop a target for future therapies.


  • Page 11

    A protein called L30 helps the body to process Intraoperative radiation therapy selenium, a trace element essential to life is beneficial for rectal cancer Understanding how selenium promotes health is A retrospective study reported by Arul Mahade- crucial to addressing diseases linked to deficien- van, M.D., Radiation Oncology, determines that cies of this mineral, such as, in some parts of the intraoperative radiation therapy improves local world, childhood cardiomyopathy. Research led control and survival in patients with recurrent or by Donna Driscoll, Ph.D., Cell Biology, identifies advanced rectal cancer. The advantage of deliver- a protein, L30, that opens a new window into the ing the radiation during surgery is that the dose unique workings of selenium and its medically can be delivered directly to the tumor bed, without important form, selenocysteine, in possibly stimu- interference from surrounding structures. lating the immune system and protecting against heart disease and cancer. Nitrous oxide does not increase the incidence of surgical wound infection Race is relevant to breast cancer survival One hundred fifty years after its first application to A retrospective study of 2,325 Northeast Ohio Af- surgery, nitrous oxide remains the most commonly rican-American and Caucasian women treated for used general anesthetic. In recent years, however, breast cancer at the Cleveland Clinic Breast Center its use has diminished worldwide because of fears finds that African-American women are more likely that its intrinsic properties may reduce surgical to die of the disease than Caucasian women. The wound healing. An international study co-authored study, led by Joseph P. Crowe, M.D., Women’s by Daniel I. Sessler, M.D., Outcomes Research, Health Center, concludes that race is an indepen- shows those fears are unfounded. The study, pub- dent factor, regardless of socioeconomic status. A lished in The Lancet, concludes this useful pathology-driven study is under way to evaluate anesthetic may continue to benefit surgical patients. the role of genetic markers. A second international trial co-authored by Dr. 8 9 Sessler, published in the Journal of the American A once-popular anti-malarial drug Medical Association, shows that supplemental may be an effective cancer treatment oxygen leads to a significant reduction in the risk Preliminary findings by Andrei Gudkov, Ph.D., of wound infection. and Katerina Gurova, Ph.D., Molecular Genetics, indicate that guinacrine, an old anti-malarial drug, Study shows patients with celiac disease have is capable of selectively killing cancer cells using a abnormal liver enzymes new mechanism that simultaneously targets two In a pilot study on patients with known celiac dis- stress-response signaling pathways known as p53 ease (a digestive disease that damages the small and NF-kappaB. The researchers plan clinical tri- intestine and interferes with absorption of nutrients als to acquire further data. from food), Jamilé Wakim-Fleming, M.D., in col- laboration with William Carey, M.D., Gastroenterol- A well-known gene may have ogy & Hepatology, finds that 40 percent of patients a not-so-well-known cancer benefit with celiac disease have abnormal liver enzymes. Although widely studied, the gene p53 may have a Drs. Carey and Wakim-Fleming are conducting heretofore undiscovered antioxidant function. Peter the initial phase of a new study to determine the M. Chumakov, M.D., Ph.D., Molecular Genetics, specific relationship between the liver, the small finds that p53 protects against reactive oxygen bowel and celiac disease. species (ROS), which can contribute to genetic mutations that lead to cancers. Understanding the role of p53 in antioxidant defense could lead to applications of antioxidants to prevent the early development of cancer in people with a p53 deficiency.


  • Page 12

    T R A N S O R M I N G F


  • Page 13

    Babies born with gastroschisis, or intestines that develop outside the abdominal wall, normally require several surgeries and months of recovery in the hospital. Now, physicians at Cleveland Clinic Children’s Hospital are transforming care for this defect through a new Fetal Care Center. Instead of multiple operations, the Fetal Care team is able to repair this defect in a single operation. Preparation begins before birth with a detailed, coordinated evaluation by experts in Maternal-Fetal Medicine, Pediatric Surgery, 10 11 Neonatology and Pediatric Radiology. The baby is delivered by cesarean section in one operating room and then rushed to a second, adjacent operating room where the surgery is performed through the native defect in the abdominal wall. Babies like Makailynn, daughter of Crystal and Wesley Currance of Ashtabula, Ohio, enjoy rapid recovery and good health. “Because we are correcting the problem in a single operation, the babies normally go home in only three weeks rather than three months,” says John DiFiore, M.D., Pediatric Surgery. Infant Makailynn Currance, back home after successful surgery for gastroschisis. Sonogram image shows a gastroschisis case in utero.


  • Page 14

    How to make artificial vascular grafts How betaherpesviruses effect more effective immunocompromised children Artificial tubes can replace or bypass blocked blood Betaherpesviruses are lifelong residents of human vessels in the body. They are less useful than they hosts and can be serious pathogens in individuals could be, however, because tissue builds up at the whose immune systems are compromised by HIV points where they are joined to the native vessel. or anti-rejection drugs. Research led by Johanna This tissue clogs the openings and reduces blood Goldfarb, M.D., Pediatric Infectious Diseases, flow. Linda M. Graham, M.D., Biomedical Engi- under a Thrasher Research Fund grant, is assess- neering, is studying ways to prevent these clogs ing the extent that these viruses are associated so that artificial blood vessels are more useful for with disease in children immunocompromised more patients. specifically by cancer and cancer therapy. The hope is to produce a more effective understanding How to do minimally invasive surgery in battle of these viruses in immunocompromised children Under a Defense Department grant, Cleveland and spur interest in evaluating therapies Clinic is developing minimally invasive surgery for preventing or treating these viruses if they are procedures that can be used to treat soldiers significant pathogens in children with cancer. The on the battlefield. Led by Isador H. Lieberman, study team includes physicians from Pediatric M.D., MBA, Orthopaedic Surgery, the grant is Hematology and Oncology as well as investigators being used to develop a minimally invasive spine from Laboratory Medicine, Biostatistics, and the surgery simulator. The project entails creating an Lerner Research Institute. ultrasound device that guides surgeons through the body to enable them to perform procedures without opening the patient, as well as developing remote sensors to measure vital signs and bodily functions in crisis situations.


  • Page 15

    How to improve deep-brain stimulation How and why blood vessels Cleveland Clinic is a leader in the use of deep- grow along with tumors brain stimulation (DBS) to reduce symptoms of What are the processes that influence the forma- Parkinson’s disease, essential tremor and dysto- tion of clots in blood vessels and the development nia. Likened to a “pacemaker for the brain,” DBS of new blood vessels in tumor growth and metas- remains in its infancy. The optimal designs and tasis? Tatiana Byzova, Ph.D., Molecular Cardiol- stimulation parameters continue to be established. ogy, is investigating the process that controls Cameron C. McIntyre, Ph.D., Biomedical Engineer- cell-matrix interactions during vascular and tumor 12 13 ing, is integrating neuroimaging, neurophysiology development. The laboratory is developing new and neuroanatomy to explain the effects of DBS approaches and therapies for cancer, heart disease and to test new stimulation strategies and elec- and numerous other conditions. trode designs. How to understand the epidemic of unrecog- nized aortic disease Some 40,000 people will die of aortic disease this year – as many as will die from breast cancer, colon cancer, traffic accidents or homicides. Yet, according to a study by Lars G. Svensson, M.D., Ph.D., Thoracic and Cardiovascular Surgery, and E. Rene Rodriguez, M.D., Anatomic Pathology, aortic disease is poorly understood and investi- gated. Why do some aortic aneurysms pop like How Alzheimer’s disease is triggered balloons, while others dissect like wafers? Drs. Genes? The environment? Both factors are being Svensson and Rodriguez say the aorta should be studied by Neuroscience’s Bruce T. Lamb, Ph.D., considered as important as any other organ in the and Riqiang Yan, Ph.D., as potential culprits in human body and, for long-term survival, should be Alzheimer’s disease. Dr. Yan’s team has identified investigated more thoroughly. a molecule that could inhibit activity of the enzyme responsible for the toxic plaque that destroys brain cells and causes Alzheimer’s pathology. The discov- ery could result in treatments that eventually prevent or treat the disease, or prevent its early onset.


  • Page 16

    TRAN S FORM IN G


  • Page 17

    Medicine is about to get very personal. Gene-based therapies soon will enable phy- sicians to customize treatment to the specific genetic/ genomic characteristics of any patient. Cleveland Clinic will help lead this transformation of medicine through its new Genomic Medicine Institute. “We’re going to gener- ate results that will allow true genomic-based, personalized healthcare,” says Charis Eng, M.D., Ph.D., Chair of the 14 15 Genomic Medicine Institute. The Institute will be a plat- form for all aspects of genomic research and medicine. It will tailor treatment, prevention and screening to patient needs. Its new home, the Center for Genomics Research building, opened in 2005 with 30,000 square feet and room for 150 personnel. The building also will house other departments involved in regenerative medicine and cellular research. It is a serious commitment to a burgeoning field. “Our ultimate goal,” says Dr. Eng, “is to be able to look at a patient and predict that he or she will get a certain disease – and then prevent it.” Charis Eng, M.D., Ph.D., Chair, Genomic Medicine Institute.


  • Page 18

    First spinal disc replacement First U.S. implant of a new min- First American medical center in Northeast Ohio iature sensor to measure pres- to use FDA-approved electro- Cleveland Clinic spine surgeon sure in the abdominal aorta magnetic navigation technol- R. Douglas Orr, M.D., performs The device is used to monitor ogy to diagnose lung disease Northeast Ohio’s first FDA- the success of a minimally Pulmonary Medicine’s Thomas approved artificial disc replace- invasive repair of an abdominal R. Gildea, M.D.; Peter J. Maz- ment surgery at Lutheran aneurysm. By monitoring pres- zone, M.D., MPH; and Atul C. Hospital. The procedure is sure inside the aneurysm sac, Mehta, M.D., pilot the use of a designed to reduce pain and the sensor has the potential to navigational technology, similar improve flexibility for patients indicate success or failure of the to that of global positioning with degenerative disc disease. procedure to protect the patient systems, to diagnose lung dis- from rupture of the aneurysm. ease. The technology uses a CT First use of a surgical robot for Kenneth Ouriel, M.D., and scan with 3-D reconstruction of spinal surgery Daniel G. Clair, M.D., Vascular bronchoscopy images to guide Isador H. Lieberman, M.D., Surgery, perform the implants. biopsy instruments to assess and Edward C. Benzel, M.D., lesions in patients for whom per- Cleveland Clinic Spine Institute, First U.S. use of a new cutaneous biopsies may be too perform the world’s first robotic prostatic urethral stent dangerous or difficult to sample spine surgery using the SpineAs- Jay P. Ciezki, M.D., Radiation using current techniques. sist robot. The surgery is made Oncology, is principal investiga- possible by Cleveland Clinic’s tor of a clinical trial by which First American protocol to collaborative relationship with the new stent is implanted in inform cancer patients of Technion University in Israel, a patient to prevent urinary fertility risks which developed the robot. obstruction after the patient Cleveland Clinic Taussig Cancer has prostate seeds implanted to Center becomes the first in First use of a novel visual treat localized prostate cancer. the United States to adopt a probe to track nitric oxide syn- structured protocol to inform all thase (NOS) in living cells First use of new device to treat age-appropriate cancer patients Dennis J. Stuehr, Ph.D., atrial septal defect in a child of their reproductive risks and and Koustubh Panda, Ph.D., Pediatric cardiologists Lourdes fertility treatment options. As a Pathobiology, collaborate on the R. Prieto, M.D., and Larry A. result, Taussig Cancer Center research, which may be valu- Latson, M.D., become the first is named the first Fertile Hope able in the study of NOS physicians in the United States Center of Excellence by Fertile as a factor in the develop- to use the Transcatheter Patch Hope, a national non-profit ment of Parkinson’s disease, to close an atrial septal defect organization. Alzheimer’s disease, arthritis (a hole in the wall between the and other conditions. heart’s right and left atria). A 7-year-old girl from Buffalo is the first to receive the catheter- delivered treatment – unique because it is metal-free – as part of an initial limited trial.


  • Page 19

    First successful use of the First U.S. trial using stem cells to First catheter intervention in CorAide left-ventricular treat patients with heart attacks an unborn child for a congeni- assist device Stephen Ellis, M.D., Cardio- tal heart defect in the Midwest This non-pulsatile heart pump, vascular Medicine, conducts A Cleveland Clinic team per- developed at Cleveland Clinic by a Phase I clinical trial to test forms an intrauterine transcath- a team led by Leonard Golding, whether injections of a drug eter balloon valvuloplasty to M.D., Biomedical Engineer- that causes a mobilization correct aortic valve stenosis, a ing, is implanted in two male of stem cells from the bone serious congenital heart defect. patients in Bad Oeynhausen, marrow into the blood are safe Correcting this defect before Germany, in February 2005. and can lead to improved left the baby is born reduces the Both patients are doing well. ventricular function following possibility of the heart develop- major heart attack. ing abnormally as a result of First FDA-approved implanta- the defect. The team perform- tion of an artificial heart as a First use of new treatment for ing the intervention includes bridge to transplant rectal tumors in Ohio Larry A. Latson, M.D., Pediatric Cleveland Clinic becomes the Cleveland Clinic colorectal Cardiology; Stephen P. Emery, first center in America to im- surgeons are the first in Ohio M.D., Pediatric Ultrasound; 16 17 plant the CardioWest Temporary to use Transanal Endoscopic and Adel K. Younoszai, M.D., Total Artificial Heart after FDA Microsurgery (TEM) to resect Echocardiology Laboratory. approval of the device. Nicholas tumors in the rectum and distal G. Smedira, M.D., Thoracic colon through the anal canal. First elbow capitellar and Cardiovascular Surgery, The procedure is a least inva- resurfacing for avascular implants the pneumatic biven- sive approach to major abdomi- necrosis – a disease resulting tricular pump to keep a patient nal surgery and is associated from a loss of blood supply alive until a transplantable with a lower tumor recurrence to the bones heart becomes available. rate compared to conventional Peter J. Evans, M.D., Ph.D., techniques when performed by Orthopaedic Surgery, replaces First endovascular tricuspid an experienced surgeon. With the cartilage surface of a badly valve implant the new procedure, patients damaged capitellum (a point Roy K. Greenberg, M.D., Vascu- avoid a stoma and experience in the elbow) with a metal- lar Surgery, and Bruce W. Lytle, minimal discomfort and a rapid lic implant. An alternative to M.D., Thoracic and Cardio- return to activity. total elbow replacement, the vascular Surgery, implant a resurfacing preserves the customized stentgraft tricuspid underlying structure of the bone valve in a patient minimally for potential later reconstruction, invasively, via catheter. The if needed. valve is contained in a flex- ible scaffold and adjusts to the variable diameter of the venous system, while the valve annulus remains a fixed diameter.


  • Page 20

    T R A N S F O R M I N G


  • Page 21

    Brain and nervous function are affected by multiple sclerosis (MS). The question is: how? Neu- rologists, radiologists and physicists at the Mellen Center for Multiple Sclerosis are transforming the study of MS by 18 19 finding out. Using MRI and other imaging tools to map the brains of MS patients, they and other researchers are trying to understand the specific brain pathways affected by MS. They are focusing on how lesions in a pathway affect specific functions, such as hand movement. They also are attempting to understand how the brain adapts to the disease. “This is a different way of looking at mul- tiple sclerosis. Understanding how individual lesions affect brain function and how the brain adapts to the presence of MS will help us develop more effective therapies,” says Micheal Phillips, M.D., Diagnostic Radiology. Neuroradiological images trace the pathways of multiple sclerosis in the brain.


  • Page 22

    Lung Pancreas Cleveland Clinic’s Lung Transplant Program The Pancreas Transplant Program performs a performs its highest number of lung transplants record number of transplants in 2005. Twenty- in 2005. Led by Medical Director Atul C. Mehta, four pancreas transplants are performed, includ- M.D., and Surgical Director Gosta Pettersson, ing 8 simultaneous pancreas-kidney transplants, M.D., Ph.D., the team performs 65 lung trans- 11 pancreas-after-kidney transplants, and five plants in 2005, surpassing its previous record-set- pancreas transplants alone. Since its founding, ting total of 64 in 2004. the Program has performed 145 transplants, with excellent outcomes. Kidney Cleveland Clinic Glickman Urological Institute cele- brates its 3,000th kidney transplant in 2005. It took 20 years to perform the first 1,000 cases, 14 years to perform the next 1,000 and only eight additional years to reach the 3,000 total transplant mark. In January 2005, President George W. Bush makes Cleveland Clinic his choice to host a national conversation on the benefits of healthcare information technology. The panel discussion with the president centers on the benefits of the electronic medical record and how this burgeoning technology will dramatically change and improve healthcare.


  • Page 23

    A remarkable number of Cleveland Clinic physicians and scientists lead their national, state or local profes- sional associations in any given year. Some are chairs, directors and executives of their associations. Here is a partial list of Cleveland Clinic leaders of professional associations who bore the title of “president” in 2005. John A. Bergfeld, M.D. Walter H. Henricks, M.D. Frank A. Papay, M.D. President, International Society of Past-President, Association Past President, Ohio Valley Society Arthroscopy, Knee Surgery and Ortho- for Pathology Informatics of Plastic Surgeons paedic Sports Medicine Keiko Hirose, M.D. Gopal Saha, Ph.D. Linda D. Bradley, M.D. President, Northeast Ohio Otolar- President, American Board of President-Elect, OB/GYN Section, yngology – Head and Neck Surgery Science in Nuclear Medicine National Medical Association Society Mark J. Sands, M.D. Brian G. Donley, M.D. Robert S. Kunkel, M.D. President and Founder, Cleveland Past President, American Orthopae- Past President, National Headache Area Angiographic Society dic Foot & Ankle Society – Young Foundation Physicians Section Philip R. Schauer, M.D. Kandice Kottke-Marchant, President-Elect, American Society for Gary W. Falk, M.D. M.D., Ph.D. Bariatric Surgery President-Elect, American Society President-Elect, International Society for Gastrointestinal Endoscopy for Laboratory Hematology Maria Siemionow, M.D., Ph.D. President, American Society Carol F. Farver, M.D. Kenneth E. Marks, M.D. for Peripheral Nerve President, Cleveland Society President, Mid-America of Pathology Orthopaedic Association Scott A. Strong, M.D. Past President, Ohio Valley Society 20 21 John R. Goldblum, M.D. Barbara Messinger-Rapport, of Colon and Rectal Surgeons President-Elect, The Gastrointestinal M.D., Ph.D. Pathology Society President, Ohio Geriatric Society Raymond R. Tubbs, D.O. President, International Society for David A. Goldfarb, M.D. Jonathan L. Myles, M.D. Analytical and Molecular Morphology President-Elect, Urologic Society of Past President, Ohio Society Transplantation and Renal Surgery of Pathologists Peter C. Weber, M.D. President-Elect, American Peter B. Imrey, Ph.D. Steven E. Nissen, M.D. Academy of Otolaryngology – Past President, Eastern North President-Elect, American College Board of Governors American Region of the International of Cardiology Biometric Society Christopher M. Whinney, M.D. President, Lake Erie Chapter, Society of Hospital Medicine Several new departmental chairs took office in 2005. These physicians represent a new generation of vigorous leadership. Charis Eng, M.D., Ph.D. Nancy J. Roizen, M.D. Daniel I. Sessler, M.D. Genomic Medicine Institute Developmental and Anesthesia Outcomes Rehabilitation Pediatrics Arthur J. McCullough, M.D. Allison T. Vidimos, M.D. Gastroenterology Lewis Rubin, M.D. Dermatology Neonatology Michael F. Roizen, M.D. Anesthesiology and Critical Martin J. Schreiber Jr., M.D. Care Medicine Nephrology and Hypertension


  • Page 24

    I G N M O R F NORMAL CANCER A N S R T


  • Page 25

    Your breath may hide a secret. Lung cancer. Long before it can be diagnosed by conventional means, lung cancer gives itself away by the presence of certain compounds in the breath. Cleveland Clinic research- ers, led by Serpil Erzurum, M.D., Chairman of Pathobiology, discovered a way of detecting these compounds using 22 23 a device called the Cyranose – a kind of electronic nose developed for the food industry. Using biosensor technol- ogy, the Cyranose can produce a “smell print” of human breath. By programming it to detect certain characteristics in breath and using algorithms to create viewable patterns, Dr. Erzurum and her team are transforming the diagnosis of lung cancer. “This method may someday enable physi- cians to determine the appropriate course for a lung cancer patient’s treatment at an earlier stage, rather than after the cancer has spread to other parts of the body and is more difficult to treat,” says Dr. Erzurum. Serpil Erzurum, M.D., Chairman, Pathobiology, with “smellprint” showing cancerous and normal compounds.


  • Page 26

    In addition to an enormous clinical practice that makes it the busiest eye institute in the country, Cleveland Clinic Cole Eye Institute also is engaged in advanced research to fight blindness and vision disorders. Here are three research projects begun or completed by the Cole Eye Institute in 2005. Beating age-related macular degeneration New treatment for difficult disease With an $18 million grant from Ohio’s Biomedi- Dr. Lewis also has developed a new treatment for cal Technology Transfer Fund, Hilel Lewis, M.D., chronic cystoid diabetic macular edema (swelling Director of the Cole Eye Institute and Chairman of of retinal tissue that decreases vision) that does not the Division of Ophthalmology, is leading a study respond to other treatments. The new technique to identify patients at risk for future development involves performing a vitrectomy (removing fluid of age-related macular degeneration. Based on the and tissue from the back of the eye with a needle) Cole Eye Institute’s discoveries regarding the pro- and draining the swollen tissue. teomics of drusen and the identification of potential biomarkers for age-related macular degeneration, Dealing with detachment the study will focus on the development of drug targets to prevent the disease from occurring. A new technique is developed at the Cole Eye Institute to treat patients with retinal detach- ment with inferior retinal breaks. The treatment is designed for people unable to hold their heads in a face-down position for days after traditional surgery or for those who need to have their vision restored quickly. This technique uses perfluorocar- bon liquids that are left in the eye for seven to 10 days, and then removed. Standard therapy has in- volved inserting a gas bubble that applies pressure to the retina while the head is held down for about two weeks, a difficult challenge for many patients. Cleveland Clinic is certified as a Primary Stroke Center by the Joint Commission on Accreditation of Healthcare Organizations (JCAHO). The designation signifies that Cleveland Clinic meets stringent national stroke care standards based on recommendations from the Brain Attack Coalition and the American Stroke Association.


  • Page 27

    “We hope our gift will encourage the Clinic “From a public health point of view, this may be to always think, believe, dream and dare to the most important study that I’ll ever do.” make it happen.” Steven E. Nissen, M.D., Cardiovascular Medicine, Sydell Miller on his 21,000-patient clinical trial to test the on her family’s $70 million gift to Cleveland safety of three popular painkillers. Clinic to name the Arnold and Sydell Miller Family Pavilion. “Only if they’ve been suffering for years and years, and feeling rejected by society, can some- “If we are to stimulate and help build the econo- one understand the importance of consenting to my of Northeast Ohio, we must address the reali- the surgery with all the consequences and risks.” ties of the knowledge economy. We are fortunate Maria Siemionow, M.D., Ph.D., Director, to have a strong healthcare establishment, which Plastic Surgery Research and Training, is founded on information and technology. To on the implications of facial tissue transplantation. continue to grow this, we are dependent upon a highly educated work force. We must educate our children and retain and attract the best and the “Buildings were damaged, but our spirits were not.” brightest to come to the Greater Cleveland area.” Robert Kay, M.D., CEO, Cleveland Clinic Florida, Delos M. Cosgrove, M.D., CEO and president, on the effects of hurricane Wilma. Cleveland Clinic, announcing a $10 million gift from Cleveland Clinic to the Cleveland Municipal “You – not your genes – control your rate of ag- School District. ing. By the time you are 80, behavioral choices 24 25 account almost entirely for your health.” “Every day, the employees of the Cleveland Clinic Michael F. Roizen, M.D., Chairman, Health System make a difference in our commu- Anesthesiology and Critical Care Medicine, nity. This difference goes beyond the provision explaining the basic message of his best-selling of outstanding patient care that is the hallmark book, “Real Age: Are You as Young as You Can Be?” of our system of hospitals, family health cen- ters and outpatient surgery facilities. Through “He is just a down-to-earth straight shooter and extraordinary community programs and other has a charisma that people gravitate to.” efforts, we are reaching out to our communities in ways that make a tremendous and positive Mark Coticchia, Vice President for Research impact on the lives of the people we touch.” at Case Western Reserve University, describing new Cleveland Clinic Chief of Staff Delos M. Cosgrove, M.D., Joseph F. Hahn, M.D. highlighting the $350 million in benefits Cleveland Clinic and its hospitals contribute to the community. “We’re trying to find out whether exercise alone will be protective for bones during long-duration “The electronic medical record is more than space flight. And bed rest is the best analog we just converting paper into digital information. have on the ground of space flight.” Rather, it is a change in the culture of medical practice so that we begin to think about using in- Peter R. Cavanagh, Ph.D., Chairman, formation in real time and sharing that informa- Biomedical Engineering, tion for the benefit of our patients.” on a Cleveland Clinic study calling for a subject to remain in bed for 12 weeks to simulate conditions C. Martin Harris, M.D., Chief Information Officer, in space. at President George W. Bush’s forum to promote electronic medical records, held at Cleveland Clinic.


  • Page 28

    T RAN SFO RMI NG


  • Page 29

    Cleveland Clinic is transforming orthopaedic surgery through transplantation and tissue engineering. America’s first tissue-engineered articular cartilage transplant was performed at Cleveland Clinic in 2005. Richard D. Parker, M.D., performed the surgery, with Anthony Miniaci, M.D., as part of a Phase I clinical trial led by Joseph Iannotti, M.D., Ph.D., Chairman of 26 27 Orthopaedic Surgery. The patient was being treated for a sports injury. The technique uses a cartilage-regeneration system that grows new tissue outside the body in 10 to 14 days. The tissue-engineered cartilage can be shaped to fit the area it is intended to repair and then attached to the surface of the bone with biological glue. In the future, the cartilage-regeneration system may be used to repair large cartilage lesions on the foot and ankle, as well as the knee. The project is part of the Department of Ortho- paedic Surgery’s program to develop and test novel tissue-engineering treatments for tendon injuries, using tissue-engineered grafts. Orthopaedic surgeon Richard D. Parker, M.D., with an illustration of transplanted articular cartilage.


  • Page 30

    “The Third Frontier” is the state of Ohio’s 10-year, $1.1 billion grant program to promote high-tech research and job creation. Cleveland Clinic plays a role in $32.8 million of “Third Frontier” grants in 2005. Atrial Fibrillation Early diagnosis and treatment Clinical Tissue Innovation Center of macular degeneration Engineering Center Cleveland Clinic partners with Cleveland Clinic Cole Eye Cleveland Clinic, Case West- Case Western Reserve Univer- Institute, Case Western Reserve ern Reserve University, NASA sity, University Hospitals Health University, Wright State Univer- Glenn Research Center, the System and 14 companies to sity and industry partners will Ohio Supercomputer Center prevent or better treat atrial accelerate studies in age-related and University Hospitals Health fibrillation, a rapid and irregular macular degeneration, which System will partner in a Clinical heartbeat. The enterprise will affects 30 percent of people Tissue Engineering Center to find new treatments for atrial over age 75. The partners will focus on creating and assess- fibrillation and turn them into aim to develop biomarkers to ing new therapies to repair marketable products to improve target in creating pharmacologi- and regenerate bone, cartilage, people’s lives. The project will cal agents to treat and prevent tendon and skin, under the create 468 jobs statewide the disease. Hilel Lewis, M.D., direction of Cleveland Clinic’s within five years and bring at Chairman of Ophthalmology George F. Muschler, M.D., least two partner companies to and Director of the Cole Eye In- Orthopaedic Surgery. Cleveland. Steven E. Nissen, stitute, is principal investigator. M.D., Cardiovascular Medicine, is principal investigator; James B. Young, M.D., Chairman, Division of Medicine, is co-prin- cipal investigator. Urologic physicians and scientists at Cleveland Clinic are recognized worldwide for excellence in patient care, teaching and research. Each of the institute’s surgeons is board-certified in urology and has subspe- cialty training in an area, such as prostate disease, bladder control or infertility. Here is a snapshot of the institute’s 2005 activities and achievements. 1 Rank in size among full-time 206 Publications in peer-reviewed journals urology faculty in America 106 Ongoing prospective clinical 1 Rank in level of research activity research projects 80,000 Outpatient visits 29 Ongoing laboratory research projects 15,000 Operations performed 2008 Scheduled opening date for the Glick- man Tower, home of the Glickman 1,200 Laparoscopic and robotic surgeries Urological Institute, Nephrology and Hypertension, and other specialties 210 Kidney transplants in combined programs


  • Page 31

    Cleveland Clinic was founded in 1921 as a not-for-profit organization with a mission to serve the communi- ty, care for the sick, and improve that care through research and education. Each year, new programs are developed and more resources are devoted to meeting community needs. This spirit of community mind- edness and compassion represents Cleveland Clinic’s ethos. Here is a sampling of the many community programs supported by Cleveland Clinic in 2005. Summer of science Bringing baby home Phone lines banish fear Forty-one students receive a tre- The Specialized Family Care Cleveland Clinic operates mendous boost from Cleveland program at the Children’s Hos- several toll-free call centers that Clinic’s new Science Internship pital Shaker Campus recruits provide free information and program. The program gives and trains people interested in peace of mind to individuals regional high school students becoming foster caregivers for and families. These include meaningful paid summer children with complex medical the Heart Center Resource and employment and mentoring in conditions or developmental Information Center, staffed medical research settings at disabilities. Each child is as- by experienced heart center Cleveland Clinic and its commu- signed a registered nurse and a nurses; Nurse-on-Call, offer- nity hospitals. “It was amazing,” social worker, while foster par- ing general information and says Bianka Jarvis, a senior at ents receive access to consider- symptom-based triage services; East High School in Cleveland. able support services. Program the Women’s Health Answer While at Cleveland Clinic, Ms. nurse Helene Wittingham, RN, Line, answered by nurses with Jarvis, who wants to become a BSN, CRRN, says the foster special training in women’s forensic scientist, worked with care program allows children health issues; and the Cancer 28 29 actual DNA samples alongside to live in a more natural family Answer Line, providing informa- scientist Satya Yadav, Ph.D., in environment and thrive in that tion and answers to questions the Cleveland Clinic Molecular environment. about cancer. “Our callers are Biotechnology Core. grateful to find someone who can answer their questions and provide reassurance,” says Mary Beth Hill, RN, BSN, Heart Center Resource and Information Center.


  • Page 32

    TRA NSF ORM ING


  • Page 33

    Cleveland Clinic is transforming screen- ing for familial cancer. Now, through genetic counseling, whole families can be advised of their risk of inherited cancer and tested for genetic mutations that are handed down from generation to generation. Thirteen members of Ohio’s Marini family came to the Taussig Cancer Center for genetic counseling, the largest single family group yet. 30 31 All were descendents of Antoinette Marini, who died of colorectal cancer in 1985. They met with experts includ- ing genetic counselor Jennifer Stein. Nine family members who were counseled chose to be tested to see if they, too, had the gene for colorectal and uterine cancer. Antoinette Marini’s daughter Vincy Judy was among those who tested positive. Now that Mrs. Judy knows she is at risk, she can get frequent screenings and be particularly alert for signs of the disease. “People don’t realize how bad colorectal cancer is,” says Mrs. Judy. “It can be cured if you catch it in time. Thank goodness for Cleveland Clinic and genetic testing.” Ken Judy, with two of his children, and their grandmother, Vincy (Marini) Judy. Graph shows gene sequencing.


  • Page 34

    CCF Innovations uses the marketplace to bring Cleveland Clinic’s home-grown inventions to the broadest possible patient population. It encourages innovation and secures resources to further Cleveland Clinic’s research mission. The following are highlights from 2005. GENERATES 3 new spin-off companies 2005 Spin Offs: RAISES $9 million in equity VioQuest Medical – Creating therapies for onco- logical, viral and autoimmune diseases. REALIZES nearly $10 million in revenue CSF Therapeutics – Caring for the aging brain WINS $33 million in by managing the fluid environment of the central commercialization grants nervous system. BUILDS a significant addition OrthoMEMS – Miniscule in-body pressure sensors to its innovation center developed by Cleveland Clinic’s BioMems group. WELCOMES Jay Yadav, M.D., CCF Innovations’ total of 15 spin offs since its as its new chairman founding is three times the national average for comparable institutions. CONVENES a record number of industry leaders, investors and clinicians (more than 850) to the 2005 Medical Innovation Summit


  • Page 35

    Cleveland Clinic Children’s Hospital provides a home-like setting for young patients and their parents. The hospital includes beds for medical/surgical, psychiatry and intensive care. The Children’s Hospital Shaker Campus offers an additional 52 beds for children requiring chronic care. The Children’s Hospital is equipped with the latest medical technology, including a computerized epilepsy monitoring unit, a consolidated pediat- ric intensive care unit, a 17-bed Level III neonatal intensive care nursery, and newly constructed operating suites. In 2002, a dedicated pediatric dialysis unit was opened at the Shaker Campus. 32 33 A few Children’s Hospital milestones in 2005: The hospital’s Pediatric Critical Care Transport Service, launched in spring 2005, transfers 900 newborns, children and adolescents from Northeast Ohio and travels to 13 states to bring patients to the Children’s Hospital for urgent, emergency and intensive care. This is 150 more transfers than projected. The Children’s Hospital has one of America’s largest pediatric gastroenterology practices. In 2005, these specialists perform 2,500 procedures, including endoscopies, sophisticated motility studies and capsule endoscopies (in which a pill-type camera is swallowed to view the intestine). The Children’s Hospital pediatric transplant specialists have a banner year, performing 10 heart transplants with zero mortality, completing a record 12 kidney transplants and expanding Cleveland Clinic’s Liver Transplant Program with the use of innovative split-graft and live-donor techniques to maximize organ use in children. The hospitals’ pediatric cardiologists continue to develop new catheter treatments for less-invasive heart de- fect repair. In 2005, the Children’s Hospital becomes first in the Midwest to open a blocked fetal heart valve in the womb, teaming with colleagues in the new multidisciplinary Fetal Care Center.


  • Page 36

    N R G T R A S F O M I N


  • Page 37

    The mission of Cleveland Clinic Lerner College of Medicine of Case Western Reserve University is to train the physician-investigators of tomorrow. Program graduates must be self-directed learners and reflective practitioners of both medicine and science. As such, a unique learning environment has been developed to fos- ter these attributes. There are no lectures in the college program. No grades or final exams. Instead, students are engaged in an interactive learning environment. From their 34 35 first year, students get clinical experience along with basic science. Interactive study is encouraged through seminars, problem sets, clinical correlations and computer-based training. Progress in core professional competencies is documented through student portfolios. Physicians and scientists act as guides and mentors, under the leader- ship of Executive Dean Andrew Fishleder, M.D. The class of 32 students entering in 2005 was selected from 728 applicants – 20 percent more than applied for the program’s first year of operation. Students of Cleveland Clinic Lerner College of Medicine interact in the school’s innovative problem-based learning program.


  • Page 38

    Stereotactic radio ablation of renal tumors Molecular genetic markers in breast cancer Representatives from Urology, Interventional Led by Joseph P. Crowe, M.D., the Molecular Radiology, Pathology and Radiation Oncology col- Genetic Markers in Breast Cancer group – an laborate to study a non-invasive treatment using interdisciplinary team of clinicians, pathologists radiation therapy to ablate, instead of remove, and basic scientists – meets weekly to facilitate the renal cell carcinoma. Their goal is to achieve the development of an integrated translational research high efficiency of a surgical or other option (like program in breast cancer. Through an innovative cryoablation or radiofrequency ablation) with the multidisciplinary collaboration involving clinical low morbidity associated with a non-invasive treat- and basic research programs, the group is applying ment. They are using the Novalis targeted radiation the latest research findings to discover better ways device. Their challenge is to deliver the radiation to successfully treat and eradicate this disease. treatment to a moving target without involving surrounding tissue. Image guidance is provided Neuroinflammation Research Center by gold reference points implanted in or near the tumor. Study leader Arul Mahadevan, M.D., Radia- Under the direction of Richard M. Ransohoff, tion Oncology, recently earned the National Cancer M.D., the Neuroinflammation Research Center is Institute’s Radiation Therapy Oncology Group’s Si- established in 2005 as a component of the Lerner mon Kramer New Investigator Award for the effort. Research Institute Department of Neurosciences. Its mission is to combine the work of clinicians and researchers from many disciplines to better understand how neuroinflammation contributes to neural injury, and to identify causes and cures for nervous system disorders. In 2005, Cleveland Clinic’s Division of Research marks 60 years of investigating the underlying causes of human diseases to help develop new treatments and cures. Today, the Lerner Research Institute is home to all laboratory-based research at Cleveland Clinic.


  • Page 39

    Pediatric heart transplant Aging Brain Clinic An Advanced Heart Failure Therapeutics Commit- The Geriatric Medicine program’s Aging Brain tee is developed by Gerard M. Boyle, M.D., Pedi- Clinic brings geriatric specialists together with doc- atric Heart Failure and Transplantation. The team tors from Neurology and Neurological Surgery to includes representatives from Pediatric Cardiac evaluate and manage patients with complex age- Surgery, Pediatric Infectious Disease, Child Psy- related disorders. Among the conditions it treats chiatry and Psychology, Nursing and Nutrition. The are adult-onset normal pressure hydrocephalus, a team meets weekly and consults on all transplant dementia-causing condition that can be reversed candidates and follows all post-heart transplant with a surgically implanted shunt. Mark Luciano, patients as a team. M.D., Ph.D., Neurology, and Robert M. Palmer, M.D., Geriatric Medicine, are co-directors. Screening for alcohol and drug abuse complications Melanoma Clinic Gregory B. Collins, M.D., Alcohol and Drug The Melanoma Clinic at the Taussig Cancer Center Recovery Center, and Jean-Pierre Yared, M.D., offers specialty care for patients with melanoma Cardiovascular Intensive Care Unit, collaborate or suspected melanoma, the most serious form of to develop a pre-operative screening protocol to skin cancer. Because early detection and treatment reduce post-operative complications from alcohol of melanomas are critical to patient survival, pa- 36 37 and drug abuse. The project is currently identifying tients are seen within 72 hours. The team includes cases at risk and gathering data on outcomes. dermatologists, plastic surgeons, medical oncolo- gists, radiation oncologists and pathologists. One Nutritional Support and Vascular Access Team patient can be evaluated by a core of melanoma experts in a single visit. The result is a consensus Patients unable to eat or absorb nutrients ad- opinion on the best course of treatment. equately receive support from this team led by Douglas L. Seidner, M.D., Gastroenterology, and Ezra Steiger, M.D., General Surgery. Including gastroenterologists, surgeons, nurses, dietitians, pharmacists, social workers and other specialists, the team follows patients from hospital to home, providing life saving parenteral nutrition and en- teral tube feeding to nearly 1,000 patients a year.


  • Page 40

    S N A R T R O F G N I M


  • Page 41

    Cleveland Clinic is at the leading edge of the worldwide transition from paper to electronic medical records. This is in large degree due to the efforts of Chief Information Officer C. Martin Harris, M.D., who has helped Cleveland Clinic become one of the first major medical 38 39 centers to make the transition to the total electronic medi- cal record. Dr. Harris, a member of the Federal Commission on Systemic Interoperability, addressed a national audience in 2005 when President George W. Bush visited Cleveland Clinic to announce his support for a national electronic medical record initiative. “The electronic medical record is more than just converting paper into digital information,” Dr. Harris said at that event. “It is a change in the culture of medical practice so that we begin to think about using information in real time and sharing that information for the benefit of our patients.” C. Martin Harris, M.D., Chief Information Officer.


  • Page 42

    Nursing education Cuyahoga County Headstart With a $1.86 million federal job-training grant, Cleveland Clinic Children’s Hospital Center for Au- Cuyahoga Community College will train Cleveland tism collaborates with the Berea Children’s Home Clinic personnel who want to become nurses and and Cuyahoga County Headstart in a three-year radiology technicians. Cleveland Clinic will subsi- program to screen, identify and refer children with dize tuition. autism and those with mental illness soon after their enrollment in Headstart. Biomechanics meeting Cancer study Cleveland Clinic, Case Western Reserve University and Cleveland State University co-sponsor the six- As part of the Case Comprehensive Cancer Insti- day joint International Society of Biomechanics and tute, scientists from Cleveland Clinic, Case Western American Society of Biomechanics meeting. The Reserve University and University Hospitals Health event draws 1,200 attendees from 18 countries. System are participating in a five-year series of stud- ies focused on possible links between obesity and Cleveland Foundation Center for Proteomics cancer. The program, Transdisciplinary Research on Energetics and Cancer, is being carried out under a grant from the National Cancer Institute. A $1.5 million grant from the Cleveland Foun- dation enables basic scientists at Case Western Reserve University School of Medicine to com- Electronic medical records bine their expertise with applied researchers at Cleveland Clinic to establish a Department of With a grant from the federal government, Cleve- Immunobiology at the school. The project is part land Clinic, The MetroHealth System, University of the Cleveland Foundation Center for Proteomics, Hospitals Health System and other hospitals are a collaboration among Cleveland Clinic, Univer- collaborating with information technology compa- sity Hospitals Health System and Case Western nies led by Northrop Grumman to devise a model Reserve University. network for electronic health data communication. Bipolar Disorder Research Center National Center for Regenerative Medicine David J. Muzina, M.D., Psychiatry and Psychol- The founding members of the National Center for ogy, continues one of the earliest of the recent Regenerative Medicine – Case Western Reserve Cleveland Clinic collaborations with Case West- University, Cleveland Clinic and University Hospi- ern Reserve University School of Medicine and tals Health System – open a new $2.1 million cell University Hospitals Health System, in the School production facility. The facility doubles the institu- of Medicine’s Bipolar Disorders Research Center. tions’ capacity to translate adult stem cell research As principal investigator of the Cleveland Clinic to the patient care realm. site, Dr. Muzina participates in interventions and research designed to improve clinical outcomes for Glickman Urological Institute: International the elderly, children and other underserved popula- Medical Advisory Board tion groups. The International Medical Advisory Board includes leading urologists from 18 countries around the world. The board serves as a vehicle for broad-scale international collaboration in education and research.


  • Page 43

    The Division of Education centrally manages a broad range of educational activities, including one of the nation’s largest graduate medical education programs. The volume and diversity of clinical problems seen by trainees at Cleveland Clinic and the opportunity to participate in a group practice model of medical care provide an ideal teaching and learning environment. Here is a snapshot of the Division’s 2005 achieve- ments and accomplishments. 59 Number of accredited Graduate Health Information Database Medical Education (GME) programs Online information on disease conditions and medical topics for the general public. 75 Number of non-accredited 6.5 million page views in 2005 GME programs clevelandclinicmeded.com 741 Number of residents and fellows in An online resource for healthcare professionals, Cleveland Clinic GME programs including the Cleveland Clinic Disease Manage- ment Project. 109 Number of advanced fellows in 1.7 million page views in 2005 Cleveland Clinic GME programs Cleveland Clinic Journal of Medicine (CCJM) 307 Number of Continuing Medical A monthly medical journal for internal medicine Education programs professionals. Among office-based internists and cardiologists, CCJM ranks No. 2 in reader- 96, 675 Number of participants in Continuing ship among the top 12 ranked internal medicine 40 41 Medical Education programs publications, according to the PERQ/HCI FOCUS December 2005 readership study. 10 Percent of attendees of live Continu- ing Medical Education programs from 101,044 – CCJM circulation outside the United States


  • Page 44

    T R A N S N G R M I F O


  • Page 45

    Outmoded nursing practices can hinder efforts to deliver excellent patient care. To avoid this, Cleveland Clinic is transforming nursing. It has established a “laboratory” for new practices called the “Nursing Unit of the Future.” The 42 43 45 nurses on the unit, G101, are piloting new products, new processes and new systems to improve clinical prac- tice and care for the unit’s cardiac surgery patients. “We’re testing and restructuring systems to work more efficiently and put patients first,” says Chief Nursing Officer Claire Young, RN, MBA. The unit also tests new technologies, new kinds of patient beds and new communications systems. Innovations that succeed on G101 can be rolled out to other units. “This is an exciting time to be a nurse at Cleveland Clinic,” says Ms. Young. “We are creating the future of nursing right here, today.” Sue Maistros, RN (left), and Chief Nursing Officer Claire Young confer in the Nursing Unit of the Future.


  • Page 46

    David L. Bronson, M.D., Chairman, Regional Medical Practice, is voted chairman-elect of the Board of Governors of the American College of Physicians, the world’s largest specialty society... the Center for Colon Polyp and Cancer Prevention, led by Carol A. Burke, M.D., celebrates its tenth anniversary in 2005... Arul Mahadevan, M.D., Radiation Oncology, proves that intraoperative radiation therapy improves local control and survival in patients with recurrent or advanced rectal cancer (fellow Ece Algur, M.D., presents the results at a national symposium)... the Center for Integrated Medicine, directed by Tanya I. Edwards, M.D., begins offering massage, acupuncture, clinical hypnotherapy and guided imagery to infertility patients at Beachwood... Antonie J. van den Bogert, Ph.D., Biomedical Engineering, wins an Academy Award for de- veloping motion-capture software, which is being used by top Hollywood producers to create 3-D animation based on human movements. His work was used in “The Lord of the Rings” movie trilogy... Allison T. Vidi- mos, M.D., becomes the first female chair of the Department of Dermatology... Leslie V. Sinclair, Cleveland Clinic Center for Autism, receives an award for “Outstanding Advocacy on Behalf of the Educational Progress of Children with Special Needs” from Individuals Devoted to Educational Advocacy... “Critical Issues in the Sedation of Pediatric Patients in the Emergency Department” is the focus of a grant chaired by Emergency Medicine’s Sharon E. Mace, M.D., to develop an evidence-based policy on pediatric procedural sedation. (Dr. Mace also publishes her 100th article/abstract in 2005, including a research article on analgesia and sedation in the peer-reviewed literature)... Ellen Rome, M.D., MPH, Pediatrics, serves as program chair for two national meetings in 2005: the annual meeting for the North American Society for Pediatric and Adolescent Gynecology, and Adolescent Medicine: PREP the Course. The latter course is co-sponsored by the American Academy of Pediatrics and the Society for Adolescent Medicine. Cleveland Clinic Press, under Executive Direc- Even Harry Potter fears Michael F. Roizen, M.D., tor/Publisher John D. Clough, M.D., and Edito- Chairman, Anesthesiology, whose book “You: The rial Director Lawrence D. Chilnick, releases its Owner’s Manual” (co-authored with Mehmet Oz, first book list, including items authored by Eric M.D.), bumps the latest tale of wizards-in-train- A. Klein, M.D.; Curtis M. Rimmerman, M.D.; ing from the top of two major best-seller lists and Michael Stanton-Hicks, M.D.; Philip R. Schauer, lands its authors on the “Oprah Winfrey Show” and M.D.; Nancy Foldvary-Schaefer, D.O.; Vance M. other national media outlets. Brown, M.D.; Tommaso Falcone, M.D.; Richard A. Prayson, M.D., and other distinguished authors, “Atlas and Manual of Cardiovascular Multidetector from both inside and outside Cleveland Clinic. Computed Tomography” by Paul Schoenhagen, M.D., Cardiovascular Medicine and Diagnostic Cleveland Clinic may become known as an incu- Radiology, establishes Cleveland Clinic’s leadership bator of best-sellers as a book in Danish by Gosta and expertise in this groundbreaking imaging tech- Pettersson, M.D., Ph.D., Thoracic and Cardio- nology. An abridged paperback version of the book vascular Surgery, becomes the top-selling book in is due in 2006. Dr. Schoenhagen also publishes Denmark. Titled “Du har rort ved mit hjerte” (“You “IVUS Made Easy” in 2005. have touched my heart”), the book is a discussion between Dr. Pettersson and Johannes Mollehave, The monumental “Gray’s Anatomy for Students” a leading Danish poet (and former patient of Dr. by Richard L. Drake, Ph.D., Director of Anatomy, Pettersson) on different aspects of the heart, from Lerner College of Medicine, is published in 2005. the literary to the scientific. It is also available in flashcard version, making it easier for medical students to test their knowledge of the human body.


  • Page 47

    Cleveland Clinic Florida, located in Weston, Fla., continues to grow and thrive. In 2005, Cleveland Clinic Florida welcomes a new CEO, Robert Kay, M.D., an experienced Cleveland Clinic administrator, former chief of staff and nationally recognized pediatric urologic surgeon. Cleveland Clinic Florida also adds a new center of excellence and increases patient capacity by 30 percent with a 31,000 square-foot build-out of existing space. Spine and Neuromuscular Center Brain Tumor Institute Cleveland Clinic Florida’s Spine and Neuromus- Cleveland Clinic Florida establishes its own Brain cular Center incorporates the Spine Institute, Tumor Institute, offering patients access to the Orthopaedic Surgery, Sports Medicine, Neurology, most current clinical trials, research and treatment Pain Management and Physical Therapy. It also in- for benign and malignant brain tumors. The insti- cludes the new areas of Pulmonary Rehabilitation tute offers a multidisciplinary team of neurosur- and Cardiac Rehabilitation. The center streamlines geons, neurologists, medical oncologists, radiation care by allowing a patient, for example, to have an oncologists and neuropathologists who collaborate MRI examined by a spine surgeon, a pain manage- to provide a full range of diagnostic, therapeutic ment specialist and a neurologist. New technology and surgical services for many types of brain ranges from enhanced radiological imaging analy- tumors, including glioblastomas, astrocytomas sis capabilities to a state-of-the-art golf simulator. and metastatic tumors. Effective management of a brain tumor often involves using a combination Cleveland Clinic hospital recognized by Soluc- of treatments. The Brain Tumor Institute utilizes the ient Top 100 Hospitals most advanced diagnostic and treatment modalities available, including stereotactic neurosurgery, radio- Cleveland Clinic hospital in Weston is named one surgery, blood-brain barrier disruption and convec- 44 45 of the nation’s 100 Top Hospitals by Evanston, tion-enhanced delivery of therapeutic agents. Ill.-based Solucient, a healthcare information firm. The award recognizes hospitals that achieve excel- lence in care quality, operational efficiency, finan- cial performance and adaptation to the environ- ment. This is the first time the 5-year-old, 150-bed hospital has been recognized by Solucient. Cleveland Clinic’s Web site (clevelandclinic.org) is a popular destination for health information and news from one of the world’s leading academic medical centers. In 2005, Web site visitors total more than 11 million, a 30% increase over 2004 totals. Patients also make 12,400 appointment requests directly through the site. Also in 2005, Cleveland Clinic is again recognized for excellence in the annual World Wide Web Health Awards, presented by the Health Information Resource Center; and the eHealthcare Leadership Awards, presented by Strategic Health Care Communications.


  • Page 48

    The Cleveland Clinic Foundation E. M. De Windt ** Samuel H. Miller * ** Board Of Trustees Chairman and CEO (Retired) Co-Chairman of the Board Eaton Corporation Forest City Enterprises, Inc. Officers Umberto P. Fedeli * James P. Mooney President and CEO Chairman and CEO A. Malachi Mixon III * The Fedeli Group Mooney Group Chairman, Board of Trustees The Cleveland Clinic Foundation Nancy F. Fisher, Esq. * Dan T. Moore III * Former Assistant Prosecutor President Chairman and CEO City of Cleveland The Dan T. Moore Company Invacare Corporation Delos M. Cosgrove, M.D.* Gay Gilanyi, Ed.D. David T. Morgenthaler ** President and CEO Founding Partner CEO and President Aquarian Show Horses, Inc. Morgenthaler The Cleveland Clinic Foundation Stephen R. Hardis * Joseph T. Gorman Bert W. Moyar Chairman and CEO President Vice President Moxahela Enterprises MEI Hotels Incorporated The Cleveland Clinic Foundation Chairman and CEO (Retired) James F. Gutierrez, M.D. William C. Mulligan Eaton Corporation The Cleveland Clinic Foundation Managing Director Primus Venture Partners David J. Hessler, Esq. * Members Senior Partner Julie Niezgoda, M.D. Wegman, Hessler & Vanderburg The Cleveland Clinic Foundation Lord Michael Ashcroft Chairman Arthur S. Holden Jr. ** John R. Nottingham BB Holdings Limited Vice President (Retired) Co-President The Coe Manufacturing Company Nottingham-Spirk Patrick V. Auletta President Emeritus Elton Hoyt III** Raymond P. Park ** Commercial Bank Keybank, N.A. President and CEO (Retired) Chairman Pickands Mather & Co. Park Corporation William W. (Bill) Baker Winfield & Associates James A. Hughes ** David F. Perse, M.D. Chairman (Retired) Chief of Staff Edward F. Bell ** First Union Real Estate Investments Chief of Surgery President and CEO (Retired) Chairman (Retired) Vice President, Medical Affairs The Ohio Bell Telephone Company Diamond Shamrock Corporation Lutheran Hospital Gordon R. Bell, M.D. Jerry V. Jarrett ** Harry T. Rein* The Cleveland Clinic Foundation Chairman and CEO (Retired) General Partner Ameritrust Corporation Foundation Medical Partners James M. Biggar ** Chairman and CEO (Retired) E. Bradley Jones ** Robert E. Rich Jr.* Glencairn Corporation Chairman and CEO (Retired) President Republic Steel Corporation Rich Products Corporation Brian J. Bolwell, M.D. The Cleveland Clinic Foundation Robert D. Kain Joseph B. Richey II President President, Technologies Division Edward B. Brandon ** IMG Sr. Vice President, Electronic & Design Engineering Chairman and CEO (Retired) Invacare Corporation National City Corporation John W. Kemper Sr. CEO and Treasurer Charles A. Rini Sr. Jeanette Grasselli Brown, Dsc. ** Avalon Precision Casting Co. Chairman of the Board and CEO Past Chair Vice President Rini Realty Company Ohio Board of Regents Treasurer, Kemper House Dennis J. Roche Stephen R. Brown Thomas G. Knoll, Esq. President Previous President Stark & Knoll, Co., L.P.A. Convention & Visitors Bureau of Greater Cleveland Alcan Rolled Products Company Stephen F. Lau, Ph.D. * Paul G. Rogers, Esq. ** David L. Bronson, M.D. President Senior Partner The Cleveland Clinic Foundation Industrial First, Inc. Hogan & Hartson, L.L.P. Flora M. Cafaro Norma Lerner Ronald J. Ross, M.D., F.A.C.R. Vice President and Assistant Treasurer Director Director Emeritus The Cafaro Company MBNA Corporation Department of Radiology Hillcrest Hospital F. Joseph Callahan ** Robert L. Lintz Chairman (Retired) Plant Manager (Retired) Hassib J. Sabbagh ** Swagelok Company General Motors Corporation Chairman Parma Metal Fabricating Division Consolidated Contractors International Jeffrey A. Cole Company, S.A.L. CEO (Retired) William E. MacDonald ** Cole National Corporation President and CEO (Retired) Bill R. Sanford* President, Cole Limited, Inc. The Ohio Bell Telephone Company Chairman SYMARK, LLC Thomas A. Commes * William E. MacDonald III * President and CEO (Retired) Vice Chairman Joseph M. Scaminace * The Sherwin-Williams Company National City Corporation President & CEO OM Group, Inc. William E. Conway ** Walter G. Maurer, M.D. Chairman The Cleveland Clinic Foundation Ralph E. Schey ** Fairmount Minerals, Ltd. Chairman and CEO (Retired) Patrick F. McCartan, Esq. * The Scott Fetzer Company William R. Cosgrove Senior Partner Chairman and CEO (Retired) Jones Day Samuel K. Scovil ** Swagelok Company Chairman and CEO (Retired) Robert F. Meyerson Cleveland-Cliffs Inc. John C. Dannemiller Chairman Chairman and CEO (Retired) Telantis Group (Naples) Applied Industrial Technologies As of March 2006 *Executive Committee Member ** Emeritus Trustee


  • Page 49

    Raymond P. Shafer, Esq. ** Guy Chisolm, Ph.D. Kenneth Ouriel, M.D. Former Governor, State of Pennsylvania Director Chairman Conflict of Interest Division of Surgery John Sherwin Jr. President John D. Clough, M.D. Deborah L. Plummer, Ph.D. Mid-Continent Ventures, Inc. Editor-In-Chief Director of Diversity Cleveland Clinic Press Jack C. Shewmaker * Derek Raghavan, M.D., Ph.D. President, J-Com, Inc. Christopher Coburn Chairman, Owner / Operator, Jac’s Ranch Executive Director Taussig Cancer Center CCF Innovations Neil P. Smith, D.O. Susan J. Rehm, M.D. Chief of Staff Robert W. Coulton Jr. Director Fairview Hospital Executive Director Physician Health Staff Affairs John W. Spirk Michael F. Roizen, M.D. Co-President Paul E. DiCorleto, Ph.D. Chairman Nottingham-Spirk Chairman Division of Anesthesiology Lerner Research Institute James P. Storer ** Ellen Rome, M.D. Past President Andrew J. Fishleder, M.D. Associate Chief of Staff Cleveland Sight Center Chairman Trustee and Secretary Division of Education David W. Rowan, Esq. George B. Storer Foundation Chief Legal Officer and Secretary Steven C. Glass Scott Strong, M.D. Chief Financial Officer Richard A. Rudick, M.D. The Cleveland Clinic Foundation Chairman Darryl E. Greene Division of Clinical Research Thomas C. Sullivan Sr. Director Chairman World Class Service William Ruschhaupt, M.D. RPM, Inc. Vice Chairman C. Martin Harris, M.D. Global Patient Services Brian J. Taussig Chief Information Officer President and CEO Chairman, Information Technology Division Donald Sinko, C.P.A. Classic Direct, Inc. Chief Integrity Officer A. Marc Harrison, M.D. Robert J. Tomsich * ** Associate Chief of Staff James K. Stoller, M.D. Chairman Director, Medical Operations Director Leadership Development NESCO, Inc. William R. Hart, M.D. Thomas V. H. Vail ** Chairman T. Declan Walsh, M.D. Division of Pathology and Laboratory Medicine Chairman Publisher and Editor (Retired) Division of Post Acute Medicine The Cleveland Plain Dealer Michael Henderson Tom Wamberg Chairman Jay Yadav, M.D. Quality and Patient Safety Institute Chairman CEO 46 47 Cleveland Clinic Innovations Chairman of the Board Cynthia Hundorfean Clark Consulting Executive Director Claire Young, R.N., M.B.A. Clinical Affairs Chief Nursing Officer Morry Weiss Chairman, Division of Nursing Chairman and CEO Robert Kay, M.D. American Greetings Corporation Chief Executive Officer James Young, M.D. Cleveland Clinic Florida Chairman Alton W. Whitehouse ** Division of Medicine Chairman and CEO (Retired) Stuart W. Kline Standard Oil Company of Ohio Director Environmental Health and Safety Loyal W. Wilson Managing Director Board Of Governors Michael Levine, M.D. Primus Venture Partners Chairman Delos M. Cosgrove, M.D. Division of Pediatrics Chairman Ralph C. Wilson Jr. ** Chairman Hilel Lewis, M.D. Joseph Hahn, M.D. Ralph C. Wilson, Jr. Enterprises Director, Cole Eye Institute Vice Chairman Buffalo Bills Chairman, Division of Ophthalmology Ivan J. Winfield Michael P. O’Boyle Roberto Llamas Chief Operating Officer Managing Partner (Retired) Chief Human Resources Officer Coopers & Lybrand Steven C. Glass Northeast Ohio Office Bruce A. Loessin Chief Financial Officer Senior Vice President and Chairman Institutional Relations and Development David W. Rowan, Esq. Chief Legal Officer and Secretary Administration Alan E. London, M.D. Executive Director Brian Bolwell, M.D. Delos M. Cosgrove, M.D. International Business Development Chief Executive Officer and President Linda Bradley, M.D. Linda McHugh David L. Bronson, M.D. Joseph Hahn, M.D. Administrator, Board of Governors Chief of Staff Martha Cathcart, M.D. Assistant Secretary Vice Chairman, Board of Governors Paul E. DiCorleto, Ph.D. Michael J. Meehan, Esq. Tomasso Falcone, M.D. Philip L. Bailin, M.D. Assistant Secretary and Senior Counsel Andrew J. Fishleder, M.D. Associate Director Leadership Development Michael J. Minnaugh Linda Graham, M.D. Treasurer Eric Klein, M.D. James M. Blazar Isador Lieberman, M.D. Chief Marketing Officer Michael T. Modic, M.D. Chairman, Division of Marketing Scott Strong, M.D. Chairman Division of Radiology T. Declan Walsh, M.D. David L. Bronson, M.D. Herbert Wiedemann, M.D. Chairman Michael P. O’Boyle, C.P.A. Division of Regional Medical Practice Linda McHugh Chief Operating Officer


  • Page 50

    Statistical Highlights Trend Analysis The Cleveland Clinic Foundation The Cleveland Clinic Foundation Patient Care 2004* 2005 Patient Care Total Clinic Visits 2,772,485 2,891,147 Total Clinic Visits (in millions) New Clinic Visits 113,461 110,184 2.7 Emergency Visits 59,367 62,841 2.5 Total Admissions (excluding newborns) 55,027 53,609** Acute 51,991 51,114 2.3 Non-Acute 3,036 2,495 02 03 04 05 Surgical Cases 68,029 69,077 Admissions (in thousands) Inpatient 24,460 24,300 55.0 Outpatient 43,569 44,777 52.5 Education 2004* 2005 50.0 Residents and Fellows in Training 833 850 Medical Students 452 470 47.5 Accredited Residency Training Programs 55 59 Allied Health Students 389 332 45.0 Programs for Allied Health Specialists 31 31 02 03 04 05 Research 2004* 2005 Surgical Cases (in thousands) 70 Total Grant and Contract Revenue $121.4M $148.8M 65 Total Federal Revenue $78.5M $90.1M Total Laboratory Investigators 146 159 60 55 Financial Highlights 50 Cleveland Clinic Health System 02 03 04 05 $ in thousands 2004* 2005 Research Total Assets 5,163,866 5,547,881 Total Federal Revenue ($ in millions) Net Assets 1,791,099 2,247,859 90 Total Operating Revenue 3,695,096 4,051,731 80 * Includes revised figures since 2004 annual report. ** In 2005, obstetrics moved to Hillcrest Hospital and inpatient psychiatry moved to 70 Lutheran Hospital. These admissions are not included in the 2005 total admissions figure for Cleveland Clinic. 60 50 02 03 04 05

  • View More

Get the full picture and Receive alerts on lawsuits, news articles, publications and more!